1. Home
  2. STAA vs EFC Comparison

STAA vs EFC Comparison

Compare STAA & EFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STAA
  • EFC
  • Stock Information
  • Founded
  • STAA 1982
  • EFC 2007
  • Country
  • STAA United States
  • EFC United States
  • Employees
  • STAA N/A
  • EFC N/A
  • Industry
  • STAA Ophthalmic Goods
  • EFC Real Estate
  • Sector
  • STAA Health Care
  • EFC Finance
  • Exchange
  • STAA Nasdaq
  • EFC Nasdaq
  • Market Cap
  • STAA 1.2B
  • EFC 1.1B
  • IPO Year
  • STAA N/A
  • EFC 2010
  • Fundamental
  • Price
  • STAA $23.33
  • EFC $12.62
  • Analyst Decision
  • STAA Buy
  • EFC Buy
  • Analyst Count
  • STAA 7
  • EFC 5
  • Target Price
  • STAA $42.83
  • EFC $13.69
  • AVG Volume (30 Days)
  • STAA 701.0K
  • EFC 886.4K
  • Earning Date
  • STAA 02-19-2025
  • EFC 02-24-2025
  • Dividend Yield
  • STAA N/A
  • EFC 12.54%
  • EPS Growth
  • STAA 9.97
  • EFC 21.68
  • EPS
  • STAA 0.44
  • EFC 1.32
  • Revenue
  • STAA $341,224,000.00
  • EFC $290,293,000.00
  • Revenue This Year
  • STAA $8.37
  • EFC N/A
  • Revenue Next Year
  • STAA $10.55
  • EFC $26.40
  • P/E Ratio
  • STAA $52.79
  • EFC $9.59
  • Revenue Growth
  • STAA 10.01
  • EFC 12.72
  • 52 Week Low
  • STAA $21.13
  • EFC $10.88
  • 52 Week High
  • STAA $52.68
  • EFC $13.46
  • Technical
  • Relative Strength Index (RSI)
  • STAA 44.66
  • EFC 58.48
  • Support Level
  • STAA $22.49
  • EFC $12.26
  • Resistance Level
  • STAA $24.50
  • EFC $12.72
  • Average True Range (ATR)
  • STAA 0.96
  • EFC 0.16
  • MACD
  • STAA 0.15
  • EFC 0.01
  • Stochastic Oscillator
  • STAA 50.24
  • EFC 78.26

About STAA STAAR Surgical Company

Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of sales are generated from the ophthalmic surgical product segment.

About EFC Ellington Financial Inc.

Ellington Financial Inc is a specialty finance company. Its primary investment objective is to generate attractive, risk-adjusted total returns for its shareholders by making investments. The company has two reportable segments; The Investment Portfolio Segment is focused on investing in a diverse array of financial assets, including residential and commercial mortgage loans, residential mortgage-backed securities, non-mortgage- and mortgage-related derivatives, debt and equity investments in loan origination companies, and other strategic investments, and The Longbridge Segment is focused on the origination and servicing of reverse mortgage loans. it acquires reverse mortgage loans both through its origination activities and through secondary market purchases.

Share on Social Networks: